The Importance of HRD Testing Over BRCA1/2 for PARP Inhibitor Therapy (Intl)

February 23, 2025
Case Studies, Oncology

A known case of Carcinoma Ovary requiring effective treatment strate-gies. PARP inhibitors target tumors with homologous recombination deficiency (HRD).

Author

Dr. Parvin Akhter Banu
Senior Consultant , Department of Oncology Labaid Cancer Hospital & Super Speciality Center

First Name

Last Name

Company

Please select your primary area of research.

Country/Region

Postal code

Would you like to speak with Strand Life Sciences expert about your project?

The Importance of HRD Testing Over BRCA1/2 for PARP Inhibitor Therapy (Intl)

Author

Contact Us